185750.KS
Chong Kun Dang Pharmaceutical Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 68,200.00
−1.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 14.25x
- P/E 2027E
- 11.84x
- P/E 2028E
- 10.46x
- P/S forward
- 0.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.73x
- PEG TTM
- —
- Price / book
- 0.93x
- Price / sales
- 0.53x
- Price / cash flow
- 7.64x
Enterprise value
- Enterprise value
- KRW 1.05T
- EV / sales
- 0.59x
- EV / EBITDA
- 8.49x
- EV / EBIT
- 13.64x
- Market cap
- KRW 941.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026